Health ProductsInformation Update

Novartis Recall of Excedrin Products Extends to Canada

· Published by Health Canada · Official notice

Details

Alert type: Information Update
Category: Drugs
Issue: Labelling and Packaging, Product Safety
Audience: General Public
Department: Health Canada
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Images

Details

Health Canada is advising Canadians that Novartis Consumer Health Inc’s U.S. recall is now being extended to Canada. According to Novartis Consumer Health Canada Inc, the Canadian recall includes all lots (expiration dates of December 20, 2014 and earlier) for over-the-counter products, Excedrin Extra Strength Caplets and Excedrin Tension Headache Caplets.

According to the FDA, Novartis Consumer Health Over-The-Counter Products: Recall - Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps and inconsistent bottle packaging clearance practices, which could result in the bottles containing foreign tablets, caplets, or capsules. The U.S. FDA has informed consumers that mixing of different products in the same bottle could result in consumers taking the incorrect product and receiving a higher or lower strength than intended or receiving an unintended ingredient. This could potentially result in overdose, interaction with other medications a consumer may be taking, or an allergic reaction if the consumer is allergic to the unintended ingredient.

Canadians can be confident that Health Canada is monitoring the voluntary recall by Novartis Consumer Health Canada Inc. Should additional information be identified, Health Canada will take appropriate action and inform Canadians.

Health Canada reminds Canadians who have concerns about these products to consult with their health care practitioner. For information concerning the recall or how to return the affected product, consumers should directly contact Novartis Consumer Health Canada Inc’s consumer relationship centre at the following number 1-888-788-8181.

Report health or safety concerns

To report suspected adverse reaction to these or other health products, please contact the Canada Vigilance Program of Health Canada toll-free at 1-866-234-2345, or complete a Canada Vigilance Reporting Form and send to us using one of these methods:

Fax: 1-866-678-6789
E-mail: CanadaVigilance@hc-sc.gc.ca
Internet: MedEffect Canada
Mail: Canada Vigilance Program
Marketed Health Products Directorate
Ottawa, ON, Address Locator 0701C
K1A 0K9

Media enquiries

Health Canada
(613) 957-2983

Public enquiries

(613) 957-2991
1-866 225-0709
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime